Telesis Bio Inc (TBIO) Stock Price, Quote & News

Company Profile

Telesis Bio, Inc., a synthetic biology company, manufactures and sells synthetic biology instruments, reagents, and associated products and related services, primarily to pharmaceutical and academic laboratories worldwide. The company offers BioXp 3250 system and BioXp 9600 system that empower researchers to go from a digital DNA sequence to endpoint-ready synthetic deoxyribonucleic acid (DNA) and messenger ribonucleic acid (mRNA) with onboard next generation sequencing (NGS) library preparation...

Industry: Medical Devices

Sector: Healthcare

Phone: 858 228 4115

Website: telesisbio.com

Address:

10431 Wateridge Circle, Suite 150, San Diego, United States

pickapenny May. 26 at 7:04 PM

$TBIO Wow...up 5000 percent today. News must be imminent. To the moon.

0 · Reply

PenkeInvesting Apr. 11 at 5:42 AM

I found you an Overbought RSI (Relative Strength Index) on the daily chart of Telesis Bio Inc.. Is that bullish or bearish? $TBIO #RsiOverbought #PINK

0 · Reply

NVDAMillionaire Mar. 26 at 4:35 PM

$TBIO Digging TBIO's mRNA play. Sanofi collab looks promising. CF program showing potential. Might take a small position if Phase 1/2 data continues to look strong. Watching closely. standout article: https://beyondspx.com/article/translate-bio-inc-tbio-a-biotech-innovator-at-the-forefront-of-mrna-therapeutics

2 · Reply

JOEYBUYDEN Feb. 13 at 6:00 PM

$TBIO wtf; wants me to buy back in huh? 😈🎲🎲🎲🎲🎲🎲🎲🎲🎲🎲🎲

0 · Reply

starforce33 Jan. 22 at 4:55 PM

$TBIO what's the story here why so low we need cash or something? Last time I traded tbio it was in the 3s 4s

1 · Reply

JOEYBUYDEN Jan. 7 at 9:25 PM

$TBIO 🖕🏽🫡

0 · Reply

JOEYBUYDEN Jan. 6 at 5:42 PM

$TBIO put this POS in the dirt! 🪦

0 · Reply

paulydestefano Dec. 30 at 4:53 AM

All eyes on ARTW this week! No dilution X micro float X 249% increase in backlog X TRUMP IS COMING IN SAVING THE AGRICULTURE SECTOR + ARTW can see a massive short squeeze! $BJDX $TBIO $UAVS $HGAS 4 other stocks that could squeeze too

0 · Reply

2pug Dec. 16 at 3:15 PM

$TBIO what is up?

0 · Reply

Noideawhatimdoing23 Dec. 7 at 8:24 PM

$TBIO so why exactly did this tank..?

0 · Reply

Telesis Bio Slides: Investor presentation

2025-05-28T13:30:16.000Z - 1 year ago

Telesis Bio, Regeneron partner for rapid DNA, gene synthesis

REGN

Nov 7, 2024, 6:00 AM EST - 1 year ago

Telesis Bio Quarterly report: Q3 2024

2024-09-25T20:15:16.000Z - 1 year ago

Telesis Bio and Beckman Coulter team to enable ‘breakthrough’ discoveries

Sep 25, 2024, 4:05 PM EDT - 1 year ago

Telesis Bio and Beckman Coulter Life Sciences Collaborate to Revolutionize DNA and mRNA Synthesis

2024-09-13T15:15:14.000Z - 1 year ago

Biotech Alert: Searches spiking for these stocks today

ALLO CDMO CRMD CRVS GNPX IONS OGI

2024-09-10T20:35:07.000Z - 1 year ago

Telesis Bio to delist shares from Nasdaq

Sep 10, 2024, 4:30 PM EDT - 1 year ago

Telesis Bio Plans to Delist its Securities from The Nasdaq Stock Market

Aug 7, 2024, 4:05 PM EDT - 2 years ago

Telesis Bio Reports Second Quarter and First Half 2024 Financial Results

Aug 7, 2024, 4:00 PM EDT - 2 years ago

Telesis Bio Quarterly report: Q2 2024

Aug 7, 2024, 4:00 PM EDT - 2 years ago

Telesis Bio Earnings release: Q2 2024

2024-08-05T14:53:02.000Z - 2 years ago

Biotech Alert: Searches spiking for these stocks today

XCUR

May 9, 2024, 4:05 PM EDT - 2 years ago

Telesis Bio Reports First Quarter 2024 Financial Results

May 9, 2024, 4:00 PM EDT - 2 years ago

Telesis Bio Quarterly report: Q1 2024

May 9, 2024, 4:00 PM EDT - 2 years ago

Telesis Bio Earnings release: Q1 2024

May 6, 2024, 4:05 PM EDT - 2 years ago

Telesis Bio Announces Reverse Stock Split

Apr 19, 2024, 8:00 AM EDT - 2 years ago

Telesis Bio Proxy statement: Proxy Filing

2024-04-18T13:03:12.000Z - 2 years ago

Telesis Bio announces strategic focus on Gibson SOLA EDS platform

Apr 18, 2024, 9:00 AM EDT - 2 years ago

Telesis Bio Inc. announces strategic focus on game-changing Gibson SOLA enzymatic DNA synthesis (EDS) platform and BioXp mRNA solutions and announces new leadership

Apr 9, 2024, 8:00 AM EDT - 2 years ago

Telesis Bio Proxy statement: Proxy Filing

Mar 28, 2024, 4:05 PM EDT - 2 years ago

Telesis Bio Reports Fourth Quarter and Full Year 2023 Financial Results

Mar 28, 2024, 4:00 PM EDT - 2 years ago

Telesis Bio Annual report: Q4 2023

Mar 28, 2024, 4:00 PM EDT - 2 years ago

Telesis Bio Earnings release: Q4 2023

Mar 6, 2024, 1:30 PM EST - 2 years ago

Telesis Bio Transcript: TD Cowen 44th Annual Health Care Conference 2024

2024-02-26T16:01:02.000Z - 2 years ago

Biotech Alert: Searches spiking for these stocks today

AGIO CARA DARE VIR

2024-02-26T16:01:02.000Z - 2 years ago

Biotech Alert: Searches spiking for these stocks today

AGIO CARA DARE VIR

2024-02-26T14:18:14.000Z - 2 years ago

Telesis Bio sees Q4 revenue $7M vs. $9.5M last year

Feb 26, 2024, 9:15 AM EST - 2 years ago

Telesis Bio Announces Select Preliminary Fourth Quarter 2023 Financial Results

2023-11-13T22:11:20.000Z - 2 years ago

Telesis Bio sees FY23 revenue $28M-$30M, consensus $33.4M

2023-11-13T22:10:13.000Z - 2 years ago

Telesis Bio reports Q3 EPS (37c), consensus (30c)

Nov 13, 2023, 4:22 PM EST - 2 years ago

Telesis Bio Reports Third Quarter 2023 Financial Results

Nov 13, 2023, 7:00 AM EST - 2 years ago

Telesis Bio Quarterly report: Q3 2023

Nov 13, 2023, 7:00 AM EST - 2 years ago

Telesis Bio Earnings release: Q3 2023

Nov 7, 2023, 9:00 AM EST - 2 years ago

Telesis Bio to Report Third Quarter Financial Results on Monday, November 13, 2023

2023-11-03T16:25:43.000Z - 2 years ago

Telesis Bio announces commercial release of cell-free amplification kit

Nov 3, 2023, 12:00 PM EDT - 2 years ago

Telesis Bio Announces Commercial Release of Cell-free Amplification Kit for Generation of Transfection-scale DNA

Sep 28, 2023, 3:48 PM EDT - 2 years ago

Telesis Bio Announces Commercial Release of BioXp® NGS Library Prep Kit for WGS

2023-08-29T20:16:32.000Z - 3 years ago

Telesis Bio names William Kullback as CFO

Aug 29, 2023, 4:05 PM EDT - 3 years ago

Telesis Bio Appoints William J. Kullback Chief Financial Officer

2023-08-11T08:47:04.000Z - 3 years ago

Telesis Bio downgraded to Sector Weight from Overweight at KeyBanc

Aug 10, 2023, 4:30 PM EDT - 3 years ago

Telesis Bio Earnings Call Transcript: Q2 2023

Aug 10, 2023, 4:30 PM EDT - 3 years ago

Telesis Bio Quarterly report: Q2 2023

Aug 10, 2023, 4:30 PM EDT - 3 years ago

Telesis Bio Earnings release: Q2 2023

Aug 10, 2023, 4:05 PM EDT - 3 years ago

Telesis Bio Reports Second Quarter 2023 Financial Results

Aug 3, 2023, 5:00 PM EDT - 3 years ago

Telesis Bio to Report Second Quarter Financial Results on Thursday, August 10, 2023

Jul 27, 2023, 8:00 AM EDT - 3 years ago

Telesis Bio Registration statement: Registration Filing

Jun 8, 2023, 9:05 AM EDT - 3 years ago

Telesis Bio to Present at Jefferies Healthcare Conference 2023

Jun 6, 2023, 3:00 AM EDT - 3 years ago

Telesis Bio to Present at Antibody Engineering and Therapeutics, Europe 2023

Jun 5, 2023, 5:30 PM EDT - 3 years ago

Telesis Bio Announces Closing of $28.0 Million Private Placement of Preferred Stock And Warrants to Purchase an Additional $46.2 Million of Common Stock

May 31, 2023, 5:29 PM EDT - 3 years ago

Telesis Bio Secures Financing of $28.0 Million

May 24, 2023, 8:00 AM EDT - 3 years ago

Telesis Bio Proxy statement: Proxy Filing

May 24, 2023, 8:00 AM EDT - 3 years ago

Telesis Bio Proxy statement: Proxy Filing

May 23, 2023, 9:00 AM EDT - 3 years ago

Telesis Bio to Present at SynBioBeta 2023

May 22, 2023, 12:00 PM EDT - 3 years ago

Telesis Bio Announces First Commercial Shipment of BioXp® Select DNA Cloning Kit

May 18, 2023, 10:00 AM EDT - 3 years ago

Telesis Bio Announces First Commercial Shipment of BioXp® NGS Library Prep Kit

May 15, 2023, 9:00 AM EDT - 3 years ago

Telesis Bio to Present at Protein Engineering Summit (PEGS Boston 2023)

May 11, 2023, 4:30 PM EDT - 3 years ago

Telesis Bio Earnings Call Transcript: Q1 2023

May 11, 2023, 4:30 PM EDT - 3 years ago

Telesis Bio Quarterly report: Q1 2023

May 11, 2023, 4:30 PM EDT - 3 years ago

Telesis Bio Earnings release: Q1 2023

May 11, 2023, 4:05 PM EDT - 3 years ago

Telesis Bio Reports First Quarter 2023 Financial Results

Apr 27, 2023, 4:05 PM EDT - 3 years ago

Telesis Bio to Report First Quarter Financial Results on Thursday, May 11, 2023

Mar 31, 2023, 9:00 AM EDT - 3 years ago

Telesis Bio Releases BioXp® Select Kits to Enable DNA Amplification and Scale-up

Mar 21, 2023, 4:30 PM EDT - 3 years ago

Telesis Bio Earnings Call Transcript: Q4 2022

Mar 21, 2023, 4:30 PM EDT - 3 years ago

Telesis Bio Annual report: Q4 2022

Mar 21, 2023, 4:30 PM EDT - 3 years ago

Telesis Bio Earnings release: Q4 2022

Mar 21, 2023, 4:05 PM EDT - 3 years ago

Telesis Bio Reports Fourth Quarter and Full Year 2022 Financial Results and Provides 2023 Guidance

Mar 16, 2023, 6:00 AM EDT - 3 years ago

Telesis Bio to Present at Festival of Biologics Conference

Mar 14, 2023, 6:00 AM EDT - 3 years ago

Telesis Bio to Present at RNA Leaders Europe Congress

Mar 9, 2023, 4:30 PM EST - 3 years ago

Telesis Bio to Report Fourth Quarter and Full Year 2022 Financial Results on Tuesday, March 21, 2023

Feb 27, 2023, 9:00 AM EST - 3 years ago

Telesis Bio to Present at the Cowen 43rd Annual Healthcare Conference

Feb 16, 2023, 9:00 AM EST - 3 years ago

Telesis Bio Releases BioXp® Select mRNA Synthesis Kit to Expand the Utility, Speed, and Impact of Its Automated Synthetic Biology Workstation

Nov 8, 2022, 4:30 PM EST - 3 years ago

Telesis Bio Earnings Call Transcript: Q3 2022

Nov 8, 2022, 4:30 PM EST - 3 years ago

Telesis Bio Quarterly report: Q3 2022

Nov 8, 2022, 4:30 PM EST - 3 years ago

Telesis Bio Earnings release: Q3 2022

Aug 8, 2022, 9:06 PM EDT - 4 years ago

Telesis Bio Earnings Call Transcript: Q2 2022

Aug 8, 2022, 9:06 PM EDT - 4 years ago

Telesis Bio Quarterly report: Q2 2022

Aug 8, 2022, 9:06 PM EDT - 4 years ago

Telesis Bio Earnings release: Q2 2022

Jul 26, 2022, 8:00 AM EDT - 4 years ago

Telesis Bio Registration statement: Registration Filing

Apr 29, 2022, 8:00 AM EDT - 4 years ago

Telesis Bio Proxy statement: Proxy Filing

Mar 23, 2022, 8:00 AM EDT - 4 years ago

Telesis Bio Annual report: Q4 2021

Sep 14, 2021, 9:26 AM EDT - 5 years ago

Sanofi completes acquisition of Translate Bio, accelerating the application of mRNA in new vaccines and therapeutics

SNY

Sep 8, 2021, 4:30 PM EDT - 5 years ago

Translate Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Aug 5, 2021, 5:11 PM EDT - 5 years ago

Translate Bio Announces Second Quarter 2021 Financial Results and Provides Corporate Update

Aug 3, 2021, 7:41 PM EDT - 5 years ago

TRANSLATE BIO INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Translate Bio - TBIO

SNY

Aug 3, 2021, 10:39 AM EDT - 5 years ago

Translate Bio Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of Translate Bio, Inc. Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm – TBIO

Aug 3, 2021, 9:23 AM EDT - 5 years ago

Translate Bio soars 30% after Sanofi agrees to buy the mRNA company for $3.2 billion

SNY

Aug 3, 2021, 8:15 AM EDT - 5 years ago

Sanofi to buy mRNA developer for $3.2 billion

SNY

Aug 3, 2021, 4:17 AM EDT - 5 years ago

Sanofi Buys U.S. Partner Translate Bio For $3.2 Billion As Pharma Giant Bets Big On mRNA Tech

SNY

Aug 3, 2021, 1:41 AM EDT - 5 years ago

Sanofi to acquire U.S.-based Translate Bio in deal valued at $3.2 billion

SNY

Aug 3, 2021, 1:28 AM EDT - 5 years ago

Sanofi confirms $3.2 billion offer to buy U.S. biotech firm Translate Bio

SNY

Aug 3, 2021, 1:00 AM EDT - 5 years ago

Sanofi to Acquire Translate Bio; Advances Deployment of mRNA Technology across Vaccines and Therapeutics Development

SNY

Aug 2, 2021, 5:46 PM EDT - 5 years ago

Exclusive-Sanofi offers to buy U.S. mRNA partner Translate Bio -sources

SNY

Jun 22, 2021, 1:00 AM EDT - 5 years ago

Sanofi and Translate Bio Initiate Phase 1 Clinical Trial of mRNA Influenza Vaccine

SNY

Jun 14, 2021, 8:00 AM EDT - 5 years ago

Telesis Bio Registration statement: Registration Filing

Jun 7, 2021, 7:30 AM EDT - 5 years ago

Translate Bio Achieves Manufacturing Milestone Related to Influenza mRNA Vaccine Program

pickapenny May. 26 at 7:04 PM

$TBIO Wow...up 5000 percent today. News must be imminent. To the moon.

0 · Reply

PenkeInvesting Apr. 11 at 5:42 AM

I found you an Overbought RSI (Relative Strength Index) on the daily chart of Telesis Bio Inc.. Is that bullish or bearish? $TBIO #RsiOverbought #PINK

0 · Reply

NVDAMillionaire Mar. 26 at 4:35 PM

2 · Reply

JOEYBUYDEN Feb. 13 at 6:00 PM

$TBIO wtf; wants me to buy back in huh? 😈🎲🎲🎲🎲🎲🎲🎲🎲🎲🎲🎲

0 · Reply

starforce33 Jan. 22 at 4:55 PM

$TBIO what's the story here why so low we need cash or something? Last time I traded tbio it was in the 3s 4s

1 · Reply

JOEYBUYDEN Jan. 7 at 9:25 PM

$TBIO 🖕🏽🫡

0 · Reply

JOEYBUYDEN Jan. 6 at 5:42 PM

$TBIO put this POS in the dirt! 🪦

0 · Reply

paulydestefano Dec. 30 at 4:53 AM

0 · Reply

2pug Dec. 16 at 3:15 PM

$TBIO what is up?

0 · Reply

Noideawhatimdoing23 Dec. 7 at 8:24 PM

$TBIO so why exactly did this tank..?

0 · Reply

NVDAMillionaire Dec. 5 at 1:40 AM

$TBIO Translate Bio, Inc. (TBIO): Navigating the Frontier of mRNA Therapeutics https://beyondspx.com/article/translate-bio-inc-tbio-navigating-the-frontier-of-mrna-therapeutics

1 · Reply

green_going_up Dec. 4 at 5:53 PM

$TBIO Beckman Coulter should just acquire this firm.

0 · Reply

JOEYBUYDEN Nov. 25 at 3:54 PM

$TBIO nightmare scenario. Do not invest!

0 · Reply

Market Cap	2,000.00
Revenue (ttm)	27.51M
Net Income (ttm)	-47.72M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-173.46%
Debt to Equity Ratio	-0.21

Volume	600
Avg Vol	1,318
Day's Range	N/A - N/A
Shares Out	1.80M
Stochastic %K	2%
Beta	2.27
Analysts	Strong Buy
Price Target	$4.00